These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30935961)

  • 1. SOX11 hypermethylation as a tumor biomarker in endometrial cancer.
    Shan T; Uyar DS; Wang LS; Mutch DG; Huang TH; Rader JS; Sheng X; Huang YW
    Biochimie; 2019 Jul; 162():8-14. PubMed ID: 30935961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of miR-203 in endometrial carcinomas.
    Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
    Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer.
    Huang YW; Liu JC; Deatherage DE; Luo J; Mutch DG; Goodfellow PJ; Miller DS; Huang TH
    Cancer Res; 2009 Dec; 69(23):9038-46. PubMed ID: 19887623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
    Zighelboim I; Goodfellow PJ; Gao F; Gibb RK; Powell MA; Rader JS; Mutch DG
    J Clin Oncol; 2007 May; 25(15):2042-8. PubMed ID: 17513808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.
    Huang YW; Luo J; Weng YI; Mutch DG; Goodfellow PJ; Miller DS; Huang TH
    Gynecol Oncol; 2010 May; 117(2):239-47. PubMed ID: 20211485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
    Li X; Wu X; Li Y; Cui Y; Tian R; Singh N; Ding M; Yang Y; Gao Y
    Oncol Rep; 2019 Apr; 41(4):2351-2360. PubMed ID: 30720133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
    Yanokura M; Banno K; Adachi M; Aoki D; Abe K
    Int J Oncol; 2017 Jun; 50(6):1934-1946. PubMed ID: 28440489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.
    Nordström L; Andersson E; Kuci V; Gustavsson E; Holm K; Ringnér M; Guldberg P; Ek S
    BMC Cancer; 2015 Apr; 15():273. PubMed ID: 25880212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
    Sernbo S; Gustavsson E; Brennan DJ; Gallagher WM; Rexhepaj E; Rydnert F; Jirström K; Borrebaeck CA; Ek S
    BMC Cancer; 2011 Sep; 11():405. PubMed ID: 21943380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma.
    Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
    Dis Markers; 2022; 2022():2676114. PubMed ID: 35465267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
    Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG
    Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
    Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
    Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
    BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas.
    Shibata D; Mori Y; Cai K; Zhang L; Yin J; Elahi A; Hamelin R; Wong YF; Lo WK; Chung TK; Sato F; Karpeh MS; Meltzer SJ
    Int J Cancer; 2006 Aug; 119(4):801-6. PubMed ID: 16557577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
    Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
    Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
    Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.
    Pugongchai A; Bychkov A; Sampatanukul P
    Int J Exp Pathol; 2017 Dec; 98(6):341-346. PubMed ID: 29315911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.
    Cosgrove CM; Cohn DE; Hampel H; Frankel WL; Jones D; McElroy JP; Suarez AA; Zhao W; Chen W; Salani R; Copeland LJ; O'Malley DM; Fowler JM; Yilmaz A; Chassen AS; Pearlman R; Goodfellow PJ; Backes FJ
    Gynecol Oncol; 2017 Sep; 146(3):588-595. PubMed ID: 28709704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
    Makabe T; Arai E; Hirano T; Ito N; Fukamachi Y; Takahashi Y; Hirasawa A; Yamagami W; Susumu N; Aoki D; Kanai Y
    Carcinogenesis; 2019 Jul; 40(5):611-623. PubMed ID: 30850842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
    Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
    Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.